Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Heme and HO-1 Inhibition of HCV, HBV, and HIV.

Schmidt WN, Mathahs MM, Zhu Z.

Front Pharmacol. 2012 Oct 4;3:129. doi: 10.3389/fphar.2012.00129. eCollection 2012.

2.

Alkylated porphyrins have broad antiviral activity against hepadnaviruses, flaviviruses, filoviruses, and arenaviruses.

Guo H, Pan X, Mao R, Zhang X, Wang L, Lu X, Chang J, Guo JT, Passic S, Krebs FC, Wigdahl B, Warren TK, Retterer CJ, Bavari S, Xu X, Cuconati A, Block TM.

Antimicrob Agents Chemother. 2011 Feb;55(2):478-86. doi: 10.1128/AAC.00989-10. Epub 2010 Dec 6.

3.

From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease.

Cígler P, Kozísek M, Rezácová P, Brynda J, Otwinowski Z, Pokorná J, Plesek J, Grüner B, Dolecková-Maresová L, Mása M, Sedlácek J, Bodem J, Kräusslich HG, Král V, Konvalinka J.

Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15394-9. Epub 2005 Oct 14.

4.

Prevention of poxvirus infection by tetrapyrroles.

Chen-Collins AR, Dixon DW, Vzorov AN, Marzilli LG, Compans RW.

BMC Infect Dis. 2003 May 28;3:9.

5.

Inactivation of human immunodeficiency virus type 1 by porphyrins.

Vzorov AN, Dixon DW, Trommel JS, Marzilli LG, Compans RW.

Antimicrob Agents Chemother. 2002 Dec;46(12):3917-25.

6.

Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro.

McPhee F, Caldera PS, Bemis GW, McDonagh AF, Kuntz ID, Craik CS.

Biochem J. 1996 Dec 1;320 ( Pt 2):681-6.

Supplemental Content

Support Center